bioRxiv
A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma
Publication
, Preprint
Somarelli, J; Rupprecht, G; Altunel, E; Flamant, E; Rao, S; Sivaraj, D; Lazarides, A; Hoskinson, S; Sheth, M; Cheng, S; Kim, SY; Ware, K ...
2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Somarelli, J., Rupprecht, G., Altunel, E., Flamant, E., Rao, S., Sivaraj, D., … Hsu, D. (2020). A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma. bioRxiv. https://doi.org/10.1101/2020.10.19.346387
Somarelli, Jason, Gabrielle Rupprecht, Erdem Altunel, Etienne Flamant, Sneha Rao, Dharshan Sivaraj, Alexander Lazarides, et al. “A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma.” BioRxiv, 2020. https://doi.org/10.1101/2020.10.19.346387.
Somarelli J, Rupprecht G, Altunel E, Flamant E, Rao S, Sivaraj D, et al. A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma. bioRxiv. 2020.
Somarelli, Jason, et al. “A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma.” BioRxiv, 2020. Epmc, doi:10.1101/2020.10.19.346387.
Somarelli J, Rupprecht G, Altunel E, Flamant E, Rao S, Sivaraj D, Lazarides A, Hoskinson S, Sheth M, Cheng S, Kim SY, Ware K, Agarwal A, Cullen M, Selmic L, Everitt J, McCall S, Eward C, Eward W, Hsu D. A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma. bioRxiv. 2020.